Key Points
-
Natural killer (NK) cells are negatively controlled by MHC class I molecules, which are recognized through inhibitory receptors. The main type of inhibitory receptors are Ly49 receptors (in mice) and killer cell immunoglobulin-like receptors (KIRs; in humans). When target cells downregulate MHC class I molecule expression, they have a 'missing-self' phenotype that is recognized by NK cells and results in their activation.
-
MHC class I molecules are also necessary for the functional development of NK cells. This process is termed 'NK cell education' and has also been referred to as 'licensing' or 'arming'. NK cells that lack inhibitory receptors or only express inhibitory receptors for which no MHC class I ligands are expressed in vivo are uneducated and hyporesponsive.
-
Successful NK cell education leads to the full functional development of NK cells, including the ability to mediate cytotoxicity and cytokine secretion. Individual NK cells are also sensitive to the strength of inhibitory input during education and set thresholds for activation that match this inhibitory input.
-
The signalling mechanisms that link the inhibitory input to functional development during NK cell education are unknown. It has also not been determined whether NK cell education is restricted to haematopoietic niches in the body and requires interactions with a particular cell, or whether it can occur everywhere after interaction with any surrounding self cell.
-
Individual Ly49 receptors and KIRs are expressed in a stochastic and independent manner on NK cells. This leads to the formation of a unique 'NK cell repertoire' in each individual, which is characterized by the coexistence of several NK cell subsets, each expressing from zero to five receptors.
-
The composition of the NK cell repertoire is determined by several factors, most of which have yet to be identified. In mice, the MHC repertoire affects the composition of the final Ly49 repertoire and thus contributes to NK cell education. A similar effect of the MHC repertoire on the human NK cell repertoire is less obvious.
-
NK cells may contribute to clinically important graft-versus-leukaemia effects following stem cell transplantation, in particular against acute myeloid leukaemia. A better understanding of NK cell education may help clinicians to find the optimal donor for each recipient, based on an analysis of their KIRs and MHC repertoire.
Abstract
From the early days of natural killer (NK) cell research, it was clear that MHC genes controlled the specificity of mouse NK cell-dependent responses, such as the ability to reject transplanted allogeneic bone marrow and to kill tumour cells. Although several mechanisms that are involved in this 'education' process have been clarified, most of the mechanisms have still to be identified. Here, we review the current understanding of the processes that are involved in NK cell education, including how the host MHC class I molecules regulate responsiveness and receptor repertoire formation in NK cells and the signalling pathways that are involved.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sun, J. C., Beilke, J. N. & Lanier, L. L. Adaptive immune features of natural killer cells. Nature 457, 557–561 (2009).
O'Leary, J. G., Goodarzi, M., Drayton, D. L. & von Andrian, U. H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nature Immunol. 7, 507–516 (2006).
Cooper, M. A. et al. Cytokine-induced memory-like natural killer cells. Proc. Natl Acad. Sci. USA 106, 1915–1919 (2009).
Orange, J. S. Human natural killer cell deficiencies. Curr. Opin. Allergy Clin. Immunol. 6, 399–409 (2006).
Khakoo, S. I. & Carrington, M. KIR and disease: a model system or system of models? Immunol. Rev. 214, 186–201 (2006).
Johansson, S., Berg, L., Hall, H. & Höglund, P. NK cells: elusive players in autoimmunity. Trends Immunol. 26, 613–618 (2005).
Karre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675–678 (1986).
Ljunggren, H. G. et al. Empty MHC class I molecules come out in the cold. Nature 346, 476–480 (1990).
Ruggeri, L. et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097–2100 (2002).
Cudkowicz, G. & Stimpfling, J. H. Induction of immunity and of unresponsiveness to parental marrow grafts in adult F-1 hybrid mice. Nature 204, 450–453 (1964).
Cudkowicz, G. Genetic control of bone marrow graft rejection. I. Determinant-specific difference of reactivity in two pairs of inbred mouse strains. J. Exp. Med. 134, 281–293 (1971).
Cudkowicz, G. & Stimpfling, J. H. Deficient growth of C57BL marrow cells transplanted in F1 hybrid mice. Association with the histocompatibility-2 locus. Immunology 7, 291–306 (1964).
Kiessling, R. et al. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur. J. Immunol. 7, 655–663 (1977).
Höglund, P. et al. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice. J. Exp. Med. 168, 1469–1474 (1988).
Ohlen, C. et al. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 246, 666–668 (1989).
Karlhofer, F. M., Ribaudo, R. K. & Yokoyama, W. M. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358, 66–70 (1992).
Kim, S. et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709–713 (2005).
Anfossi, N. et al. Human NK cell education by inhibitory receptors for MHC class, I. Immunity 25, 331–342 (2006).
Johansson, S. et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J. Exp. Med. 201, 1145–1155 (2005). This study was the first to show that different MHC class I alleles have a unique 'educating impact' on the NK cell system, suggesting that NK cell education may be a quantitative process.
Fernandez, N. C. et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105, 4416–4423 (2005). References 17, 18 and 20 were the first to link MHC class I-dependent functional maturation with inhibitory receptors and to demonstrate the presence of uneducated NK cells in normal individuals.
Moretta, L. & Moretta, A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23, 255–259 (2004).
Lanier, L. L. NK cell recognition. Annu. Rev. Immunol. 23, 225–274 (2005).
Parham, P. MHC class I molecules and KIRs in human history, health and survival. Nature Rev. Immunol. 5, 201–214 (2005).
Carlyle, J. R. et al. Evolution of the Ly49 and Nkrp1 recognition systems. Semin. Immunol. 20, 321–330 (2008).
Braud, V. M. et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and, C. Nature 391, 795–799 (1998).
Vance, R. E., Kraft, J. R., Altman, J. D., Jensen, P. E. & Raulet, D. H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1b. J. Exp. Med. 188, 1841–1848 (1998).
Lopez-Botet, M., Angulo, A. & Guma, M. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 63, 195–203 (2004).
Ciccone, E. et al. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur. J. Immunol. 24, 1003–1006 (1994).
Valiante, N. M. et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7, 739–751 (1997).
Bix, M. et al. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 349, 329–331 (1991).
Höglund, P. et al. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m− mice: nonresponsiveness controlled by beta 2m− bone marrow in chimeric mice. Proc. Natl Acad. Sci. USA 88, 10332–10336 (1991).
Liao, N. S., Bix, M., Zijlstra, M., Jaenisch, R. & Raulet, D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253, 199–202 (1991).
Zimmer, J. et al. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J. Exp. Med. 187, 117–122 (1998).
Brodin, P., Lakshmikanth, T., Johansson, S., Karre, K. & Höglund, P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113, 2434–2441 (2009). References 34 and 49 were the first to show that the strength of inhibitory input by MHC class I molecules through inhibitory Ly49 receptors determines the threshold for activation of NK cells.
Orr, M. T., Murphy, W. J. & Lanier, L. L. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nature Immunol. 11, 321–327 (2010).
Tay, C. H., Welsh, R. M. & Brutkiewicz, R. R. NK cell response to viral infections in beta 2-microglobulin-deficient mice. J. Immunol. 154, 780–789 (1995). References 35 and 36 showed that 'uneducated' NK cells can clear MCMV infection, questioning the importance of education for some NK cell-mediated functions in vivo.
Lucas, M., Schachterle, W., Oberle, K., Aichele, P. & Diefenbach, A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503–517 (2007).
Chaix, J. et al. Cutting edge: priming of NK cells by IL-18. J. Immunol. 181, 1627–1631 (2008).
Peterson, M. E. & Long, E. O. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 29, 578–588 (2008). This study provided new insights into inhibitory signalling and showed that CRK was phosphorylated by the kinase ABL1 downstream of inhibitory receptors, identifying potential ways by which inhibitory receptor signalling might affect the activating signals that are needed for NK cell education.
Yokoyama, W. M. Inhibitory receptors signal activation. Immunity 29, 515–517 (2008).
Yokoyama, W. M. & Kim, S. Licensing of natural killer cells by self-major histocompatibility complex class, I. Immunol. Rev. 214, 143–154 (2006).
Raulet, D. H. & Vance, R. E. Self-tolerance of natural killer cells. Nature Rev. Immunol. 6, 520–531 (2006).
Doucey, M. A. et al. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nature Immunol. 5, 328–336 (2004).
Zimmer, J., Ioannidis, V. & Held, W. H-2D ligand expression by Ly49A+ natural killer (NK) cells precludes ligand uptake from environmental cells: implications for NK cell function. J. Exp. Med. 194, 1531–1539 (2001).
Chalifour, A. et al. A Role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 30, 337–347 (2009). This study presented a new model for NK cell education based on cis interactions between Ly49 receptors and MHC class I molecules on the NK cell membrane.
Andersson, K. E., Williams, G. S., Davis, D. M. & Höglund, P. Quantifying the reduction in accessibility of the inhibitory NK cell receptor Ly49A caused by binding MHC class I proteins in cis. Eur. J. Immunol. 37, 516–527 (2007).
Back, J. et al. Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. Immunity 31, 598–608 (2009).
Brodin, P., Karre, K. & Höglund, P. NK cell education: not an on–off switch but a tunable rheostat. Trends Immunol. 30, 143–149 (2009).
Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E. & Raulet, D. H. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J. Immunol. 182, 4572–4580 (2009).
Brodin, P. & Höglund, P. Beyond licensing and disarming: a quantitative view on NK-cell education. Eur. J. Immunol. 38, 2934–2937 (2008).
Lanier, L. L. Up on the tightrope: natural killer cell activation and inhibition. Nature Immunol. 9, 495–502 (2008).
Stebbins, C. C. et al. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell Biol. 23, 6291–6299 (2003). This study provided the first evidence that inhibitory receptor signalling could terminate activating signals by dephosphorylating VAV1, a common factor in both inhibitory and activating pathways.
Bryceson, Y. T., March, M. E., Ljunggren, H. G. & Long, E. O. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214, 73–91 (2006).
Kim, H. S., Das, A., Gross, C. C., Bryceson, Y. T. & Long, E. O. Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity 32, 175–186 (2010).
Yawata, M. et al. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 112, 2369–2380 (2008).
Fauriat, C., Ivarsson, M. A., Ljunggren, H. G., Malmberg, K. J. & Michaelsson, J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115, 1166–1174 (2010).
Lowin-Kropf, B., Kunz, B., Beermann, F. & Held, W. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. J. Immunol. 165, 1314–1321 (2000).
Jonsson, A. H., Yang, L., Kim, S., Taffner, S. M. & Yokoyama, W. M. Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J. Immunol. 184, 3424–3432 (2010).
Yusa, S. & Campbell, K. S. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells. J. Immunol. 170, 4539–4547 (2003).
Wang, J. W. et al. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science 295, 2094–2097 (2002).
Fortenbery, N. R. et al. SHIP influences signals from CD48 and MHC class I ligands that regulate NK cell homeostasis, effector function, and repertoire formation. J. Immunol. 184, 5065–5074 (2010).
Shultz, L. D., Rajan, T. V. & Greiner, D. L. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnol. 15, 302–307 (1997).
Tsui, F. W., Martin, A., Wang, J. & Tsui, H. W. Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1. Immunol. Res. 35, 127–136 (2006).
Jonsson, A. H. & Yokoyama, W. M. Natural killer cell tolerance licensing and other mechanisms. Adv. Immunol. 101, 27–79 (2009).
Di Santo, J. P. Natural killer cells: diversity in search of a niche. Nature Immunol. 9, 473–475 (2008).
Saleh, A. et al. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 21, 55–66 (2004).
Davies, G. E. et al. Identification of bidirectional promoters in the human KIR genes. Genes Immun. 8, 245–253 (2007).
Andersson, S., Fauriat, C., Malmberg, J. A., Ljunggren, H. G. & Malmberg, K. J. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 114, 95–104 (2009).
Johansson, S. et al. Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice. PLoS One 4, e6046 (2009).
Held, W., Dorfman, J. R., Wu, M. F. & Raulet, D. H. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur. J. Immunol. 26, 2286–2292 (1996).
Salcedo, M. et al. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J. Immunol. 158, 3174–3180 (1997). References 70 and 71 showed a role for MHC class I molecules in the shaping of the inhibitory receptor repertoire.
Hanke, T., Takizawa, H. & Raulet, D. H. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur. J. Immunol. 31, 3370–3379 (2001).
Lowin-Kropf, B., Kunz, B., Schneider, P. & Held, W. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. Eur. J. Immunol. 32, 773–782 (2002).
Whittaker, G. C. et al. Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire. Blood 112, 2869–2877 (2008).
Coudert, J. D., Scarpellino, L., Gros, F., Vivier, E. & Held, W. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood 111, 3571–3578 (2008).
Oppenheim, D. E. et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nature Immunol. 6, 928–937 (2005).
Wiemann, K. et al. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J. Immunol. 175, 720–729 (2005).
Tripathy, S. K. et al. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J. Exp. Med. 205, 1829–1841 (2008).
Sun, J. C. & Lanier, L. L. Tolerance of NK cells encountering their viral ligand during development. J. Exp. Med. 205, 1819–1828 (2008). References 76–79 provided evidence for induced hyporesponsiveness following continuous stimulation of activating NK cell receptors by a transgenically expressed ligand in vivo.
Yokoyama, W. M. & Kim, S. How do natural killer cells find self to achieve tolerance? Immunity 24, 249–257 (2006).
Fauriat, C. et al. Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype. J. Immunol. 181, 6010–6019 (2008).
Fahlen, L., Lendahl, U. & Sentman, C. L. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells. J. Immunol. 166, 6585–6592 (2001).
Raulet, D. H. et al. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 155, 41–52 (1997).
Kim, S. et al. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl Acad. Sci. USA 105, 3053–3058 (2008).
Di Santo, J. P. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24, 257–286 (2006).
Cella, M. et al. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J. Exp. Med. 200, 817–823 (2004).
Malarkannan, S. et al. Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation. J. Immunol. 179, 3752–3762 (2007).
Gross, O. et al. Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-κB and MAPK activation to selectively control cytokine production. Blood 112, 2421–2428 (2008).
Hara, H. et al. Cell type-specific regulation of ITAM-mediated NF-κB activation by the adaptors, CARMA1 and CARD9. J. Immunol. 181, 918–930 (2008).
Chiesa, S. et al. Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107, 2364–2372 (2006).
Bloch-Queyrat, C. et al. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J. Exp. Med. 202, 181–192 (2005).
Mason, L. H., Willette-Brown, J., Taylor, L. S. & McVicar, D. W. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J. Immunol. 176, 6615–6623 (2006).
Shier, P. et al. Impaired immune responses toward alloantigens and tumor cells but normal thymic selection in mice deficient in the β2 integrin leukocyte function-associated antigen-1. J. Immunol. 157, 5375–5386 (1996).
Schmits, R. et al. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J. Exp. Med. 183, 1415–1426 (1996).
Matsumoto, G., Nghiem, M. P., Nozaki, N., Schmits, R. & Penninger, J. M. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity. J. Immunol. 160, 5781–5789 (1998).
Gilfillan, S., Ho, E. L., Cella, M., Yokoyama, W. M. & Colonna, M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nature Immunol. 3, 1150–1155 (2002).
Horng, T., Bezbradica, J. S. & Medzhitov, R. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nature Immunol. 8, 1345–1352 (2007).
Tassi, I. et al. DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo. Eur. J. Immunol. 39, 1129–1135 (2009).
Zompi, S. et al. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nature Immunol. 4, 565–572 (2003).
Bakker, A. B. et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13, 345–353 (2000).
Huntington, N. D., Xu, Y., Nutt, S. L. & Tarlinton, D. M. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells. J. Exp. Med. 201, 1421–1433 (2005).
Hesslein, D. G., Takaki, R., Hermiston, M. L., Weiss, A. & Lanier, L. L. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc. Natl Acad. Sci. USA 103, 7012–7017 (2006).
Yamada, H., Kishihara, K., Kong, Y. Y. & Nomoto, K. Enhanced generation of NK cells with intact cytotoxic function in CD45 exon 6-deficient mice. J. Immunol. 157, 1523–1528 (1996).
Cruz-Munoz, M. E., Dong, Z., Shi, X., Zhang, S. & Veillette, A. Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function. Nature Immunol. 10, 297–305 (2009).
Roncagalli, R. et al. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nature Immunol. 6, 1002–1010 (2005).
Dong, Z. et al. Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nature Immunol. 10, 973–980 (2009).
Guerra, N. et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28, 571–580 (2008).
Zafirova, B. et al. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 31, 270–282 (2009).
Colucci, F. et al. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nature Immunol. 3, 288–294 (2002).
Regunathan, J. et al. Differential and nonredundant roles of phospholipase Cγ2 and phospholipase Cγ1 in the terminal maturation of NK cells. J. Immunol. 177, 5365–5376 (2006).
Caraux, A. et al. Phospholipase C-γ2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood 107, 994–1002 (2006).
Kim, N. et al. The p110δ catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion. Blood 110, 3202–3208 (2007).
Tassi, I. et al. p110γ and p110δ phosphoinositide 3-kinase signaling pathways synergize to control development and functions of murine NK cells. Immunity 27, 214–227 (2007).
Guo, H., Samarakoon, A., Vanhaesebroeck, B. & Malarkannan, S. The p110 δ of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation. J. Exp. Med. 205, 2419–2435 (2008).
Awasthi, A. et al. Deletion of PI3K-p85α gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells. Genes Immun. 9, 522–535 (2008).
Tomasello, E. et al. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13, 355–364 (2000).
Acknowledgements
The authors would like to express their thanks to all members of the Höglund group for important scientific input, to E. Long for critical reading of the manuscript and to K. Kärre and all members of his group for stimulating discussions. Work in our group is supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institutet, the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), the Marianne and Marcus Wallenberg Foundation and the Mary Bevé Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information S1 table
Genetic modulation of molecules involved in activating receptor signalling in mouse NK cells (PDF 185 kb)
Related links
Glossary
- Killer cell immunoglobulin-like receptors
-
(KIRs). These receptors, which are encoded on human chromosome 19, are expressed by natural killer cell subsets and by a minor population of T cells. Inhibitory KIRs have locus and allele specificity for MHC class I molecules.
- Missing-self recognition
-
The recognition and attack of cells that do not express MHC class I molecules — in other words, that are 'missing self' — by natural killer cells. This provides a surveillance mechanism to detect virally infected or transformed cells that downregulate MHC class I expression.
- Graft-versus-leukaemia
-
An immune response that is mounted by the transplanted cells against the tumour cells of the host. This response is one of the reasons why allogeneic transplants can be curative for cancer.
- β2-microglobulin
-
(β2m). A single immunoglobulin-like domain that non-covalently associates with the main polypeptide chain of MHC class I molecules. In the absence of β2m, MHC class I molecules are unstable and are therefore found at very low levels at the cell surface.
- Anergy
-
A state of T cell unresponsiveness following stimulation with an antigen. It can be induced by stimulation with a large amount of a specific antigen in the absence of engagement of co-stimulatory molecules.
- E3 ubiquitin ligase
-
The enzyme that is required to attach the molecular tag ubiquitin to proteins that are destined for degradation by the proteasomal complex.
- Motheaten viable mice
-
(mev/mev mice). Mice that have a mutation in the coding region of the catalytic domain of SH2-domain-containing protein tyrosine phosphatase 1 (SHP1), which results in two aberrant loss-of-function proteins (one of 67 kDa and one of 71 kDa). These mice develop severe combined immunodeficiency and systemic autoimmunity.
- Antibody-dependent cell-mediated cytotoxicity
-
A mechanism by which natural killer (NK) cells kill other cells, such as virus-infected target cells that are coated with antibodies. The Fc portions of the coating antibodies interact with the Fc receptor (FcγRIII; also known as CD16) that is expressed by NK cells, thereby initiating a signalling cascade that results in the release of cytotoxic granules (containing perforin and granzyme B), which induce apoptosis of the antibody-coated cell.
Rights and permissions
About this article
Cite this article
Höglund, P., Brodin, P. Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol 10, 724–734 (2010). https://doi.org/10.1038/nri2835
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri2835
This article is cited by
-
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
Cancer Immunology, Immunotherapy (2024)
-
Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells
Leukemia (2023)
-
Key features and homing properties of NK cells in the liver are shaped by activated iNKT cells
Scientific Reports (2019)
-
Synergized regulation of NK cell education by NKG2A and specific Ly49 family members
Nature Communications (2019)
-
Differences in MHC-B diversity and KIR epitopes in two populations of wild chimpanzees
Immunogenetics (2019)